Helvetica Chimica Acta Vol.85 (2002)
1521
Experimental Part
General.Chemicals used were commercially available from ACROS.The mesogenic behaviors and phase
transitions were characterized by polarizing optical microscopy and differential scanning calorimetry (Perkin-
Elmer DSC 6).FT-IR Spectra [cm À1]: Perkin Elmer RX-I. 1H-NMR: Varian 300 FT-NMR spectrometer;
13C-NMR spectra: Bruker 200 FT-NMR spectrometer; d in ppm; J values in Hz.HR-EI-MS: VG70-250; 70 eV.
Synthesis of Compounds 1a 1c. A soln. of PhOH (1.88 g, 20 mmol) and KOH (1.12 g, 20 mmol) in H2O
(20 ml) was added to a soln.of [4-(ethoxycarbonyl)benzene]diazonium tetrafluoroborate (1; 5.17 g) in EtOH.
The soln.was then stirred at rt..for 2 h.A suitable amount of aq.HCl was added to maintain the resulting soln.
slightly acidic (pH 5 6).The product precipitated was filtered off and purified by chromatography to give
2.45 g (45.4%) of ethyl 4-[(4-hydroxyphenyl)diazenyl]benzoate (3a).Similarly, ethyl 4-[(3-fluoro-4-hydroxy-
phenyl)diazenyl]benzoate (3b) and ethyl 4-[(2-fluoro-4-hydroxyphenyl)diazenyl]benzoate (3c) were obtained
in 57.7% (3.3 g) and 48.5% (2.79 g) yields, resp. Reaction of compounds 3a 3c (2 mmol) with decanoyl chloride
(2 mmol) in CH2Cl2 with excess Et3N yielded the desired corresponding products 1a 1c in ca.85% yield after
normal workup.
Data of Ethyl 4-{[4-(Decanoyloxy)phenyl]diazenyl}benzoate (1a): 84.7% (0.72 g). IR: 3130, 2955, 2921,
2849, 2363, 1942, 1753, 1713, 1601, 1581, 1491, 1466, 1413. 1H-NMR (CDCl3): 0.85 (t, J 5.4, Me); 1.26 1.53
(m, 6 CH2, Me); 1.69 1.78 (m, CH2); 2.57 (t, J 7.8, CH2); 4.40 (q, J 7.2, CH2); 7.24 (AA'BB', J 8.7,
2 arom.H); 7.91 ( AA'BB', J 8.7, 2 arom. H); 7.97 (AA'BB', J 8.7, 2 arom. H); 8.17 (AA'BB', J 8.7,
2 arom.H). 13C-NMR (CDCl3): 171.84; 165.98 (CO); 154.97; 153.32; 150.06; 132.19; 130.53; 124.33; 122.57;
122.31; 61.22; 34.41; 31.83; 29.38; 29.23; 29.08; 24.86; 22.63; 14.30; 14.07. HR-MS: 424.2361 (C25H32N2O4; calc.
424.2362).
Data of Ethyl 4-{[4-(Decanoyloxy)-3-fluorophenyl]diazenyl}benzoate (1b): 73.6% (0.65 g). IR: 2956, 2917,
2350, 1750, 1714, 1601, 1598, 1507, 1493, 1490, 1428, 1410. 1H-NMR (CDCl3): 0.87 (t, J 5.4, Me), 1.26 1.54
(m, 6 CH2; Me); 1.69 1.80 (m, CH2); 2.62 (t, J 7.5, CH2); 4.40 (q, J 7.2, CH2); 7.30 (t, J 7.5, 1 arom. H); 7.74
(2d, J 9.0, 2.4, 1 arom. H); 7.81 (2d, J 9.0, 2.4, 1 arom. H); 7.92 (AA'BB', J 8.7, 2 arom. H); 8.17
(AA'BB', J 8.7, 2 arom. H). 13C-NMR (CDCl3): 170.87; 165.87 (CO); 156.21; 154.62; 152.87; 150.86;
140.94; 140.76; 132.59; 130.56; 124.03; 122.74; 121.57; 109.34; 109.07; 61.27; 33.89; 31.82; 29.36; 29.20; 28.98;
24.84; 22.63; 14.28; 14.06. HR-MS: 442.2268 (C25H31FN2O4; calc.4422. 268).
Data of Ethyl 4-{[4-(Decanoyloxy)-2-fluorophenyl]diazenyl}benzoate (1c): 68.2% (0.60 g). IR: 3117, 2956,
2920, 2850, 1758, 1714, 1610, 1587, 1485, 1468, 1427, 1412. 1H-NMR (CDCl3): 0.87 (t, J 5.4, Me); 1.22 1.55
(m, 6 CH2, Me); 1.63 1.80 (m, CH2); 2.57 (t, J 7.5, CH2); 4.40 (q, J 7.2, CH2); 6.96 (2d, J 9.0, 2.1,
1 arom.H); 7.12 (2 d, J 10.8, 2.1, 1 arom. H); 7.81 (t, J 8.7, 1 arom. H); 7.95 (AA'BB', J 8.7, 2 arom. H); 8.18
(AA'BB', J 8.7, 2 arom. H). 13C-NMR (CDCl3): 171.35; 165.91 (CO); 162.24; 158.78; 155.06; 154.25; 154.11;
138.28; 138.19; 132.55; 130.54; 122.84; 118.71; 117.82; 111.11; 110.80; 61.26; 34.34; 31.82; 29.36; 29.21; 29.03;
24.76; 22.63; 14.29; 14.06. HR-MS: 442.2267 (C25H31FN2O4; calc.4422. 268).
X-Ray Crystal-Structure Analysis.Crystals of compounds 1a 1c were grown from CH2Cl2/hexane 1:1 at r.t.
Single crystal of suitable quality was mounted on a glass fiber and used for measurement of precise cell constants
and intensity data collection.Diffraction measurement was made on a Siemens SMART 1K CCD diffractometer
with graphite-monochromated MoKa radiation (l 0.71073 ä). No significant decay was observed during the
data collection.Data were processed on a PC with SHELXTL software package [13].The structures of 1a 1c
were solved by direct methods and refined by full-matrix least-squares on F2 value.All non-H-atoms were
refined anisotropically.The H-atoms were fixed at calculated positions and refined using a riding model.Other
data for compounds 1a 1c were as follows.
≈
Compound 1a: C25H32N2O4, P1, triclinic, a 5.5711(6), b 8.4652(10), c 26.459(3) ä, a 94.993(2), b
92.682(2), g 105.334(2)8, V 1195.6 ä3, Z 2, q 1.55 27.558, data collection at 293 K, reflections
measured 14191, reflections used 5462 ((Rint) (0.0593)), R 0.0655.
≈
Compound 1b: C25H31FN2O4, P1, triclinic, a 6.1291(7), b 8.1812(9), c 25.910(3) ä, a 83.859(2), b
87.415(2), g 70.006(2)8, V 1213.9 ä3, Z 2, q 1.58 27.528, data collection at 293 K, reflections meas-
ured 14215, reflections used 5494 ((Rint) (0.0573)), R 0.0473.
≈
Compound 1c: C25H31FN2O4, P1, triclinic, a 5.3563(9), b 6.3360(11), c 37.519(6) ä, a 87.162(3),
b 87.465(3), g 77.650(2)8, V 1241.6 ä3, Z 2, q 1.63 24.998, data collection at 150 K, reflections
measured 7219, reflections used 3984 ((Rint) (0.0400)), R 0.0817. Crystallographic data for the com-
pounds 1a 1c reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as
supplementary publication No.CCDC-163831, 163832, and 17380, resp.Copies of the data can be obtained free